Stockscreener 앱 받기
24.81
3.61%
-0.93
전일 마감가:
$25.74
열려 있는:
$25.88
하루 거래량:
4.04M
Relative Volume:
0.70
시가총액:
$2.79B
수익:
-
순이익/손실:
$-99.15M
주가수익비율:
-26.68
EPS:
-0.93
순현금흐름:
$-74.25M
1주 성능:
-8.04%
1개월 성능:
-37.76%
6개월 성능:
-16.04%
1년 성능:
-60.50%
1일 변동 폭
$24.80
$25.89
1주일 범위
$24.80
$26.84
52주 변동 폭
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
24.81 | 2.91B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Goldman | Neutral |
| 2025-02-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-07 | 개시 | Citigroup | Neutral |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
This Under-the-Radar Healthcare Stock Could Soar in 2026 - AOL.com
This Under-the-Radar Healthcare Stock Could Soar in 2026 - The Motley Fool
Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback - Mitrade
Alliancebernstein L.P. Decreases Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Comerica Bank Sells 20,767 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Curi RMB Capital LLC Grows Stock Holdings in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX) Valuation: Are Investors Paying Too Much for Future Growth? - simplywall.st
Where Does VKTX Stock Stand After the Obesity Pill Setback? - Zacks Investment Research
Viking Therapeutics (VKTX): Reassessing Valuation After Clinical Trial Setback and Weak Earnings - Yahoo Finance
Eventide Asset Management LLC Sells 187,290 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
EFG Asset Management North America Corp. Sells 22,649 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Cinctive Capital Management LP Buys 42,344 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Granahan Investment Management LLC Raises Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics Concludes Broad Manufacturing Agreement With CordenPharma To Support Commercialization of VK2735 - MSN
Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate - MSN
Insider Trends: What’s the analyst consensus on Viking Therapeutics Inc2025 Top Decliners & High Accuracy Investment Entry Signals - Lancaster City Council
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy? - MSN
Viking Therapeutics (VKTX) Gets a Buy from Piper Sandler - The Globe and Mail
Published on: 2025-09-09 13:05:54 - Lancaster City Council
Viking Therapeutics (VKTX) Slashes 42% on Huge Clinical Study Dropout Rate - MSN
Is Summit Therapeutics a Buy, Sell, or Hold Now? - AOL.com
Why Is Viking Therapeutics Stock (VKTX) Down 40% Today? - MSN
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Viking Therapeutics at Morgan Stanley Conference: Expanding Obesity Treatment Horizons - Investing.com
Viking Therapeutics Inc. Outperforms Peers on Volume MetricsJuly 2025 WrapUp & Accurate Intraday Trade Tips - beatles.ru
Viking Therapeutics Shares Under Pressure Amid Losses - TipRanks
Jim Cramer Recommends Eli Lilly Over Viking Therapeutics - Insider Monkey
Magnetar Financial LLC Decreases Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. - MSN
ADAR1 Capital Management LLC Buys 50,113 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Can Viking Therapeutics Inc. lead its sector in growthVolume Spike & Verified Technical Trade Signals - beatles.ru
Trend analysis for Viking Therapeutics Inc. this week2025 Major Catalysts & Target Return Focused Picks - Newser
When is the best time to exit Viking Therapeutics Inc.2025 Volatility Report & Stock Portfolio Risk Control - Newser
Can swing trading help recover from Viking Therapeutics Inc. lossesM&A Rumor & Daily Stock Trend Reports - Newser
Can Viking Therapeutics Inc. withstand a market correctionQuarterly Earnings Summary & Weekly Hot Stock Watchlists - خودرو بانک
Is Viking Therapeutics Inc. stock heavily shortedEarnings Beat & Daily Price Action Insights - خودرو بانک
Can Viking Therapeutics Inc. outperform in the next rallyQuarterly Investment Review & AI Based Buy and Sell Signals - خودرو بانک
Landscape Capital Management L.L.C. Buys Shares of 10,003 Viking Therapeutics, Inc. $VKTX - MarketBeat
Apis Capital Advisors LLC Increases Stock Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Why Viking Therapeutics Inc. is moving today2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Will Viking Therapeutics Inc. benefit from macro trends2025 Risk Factors & Expert Approved Trade Ideas - Newser
Market reaction to Viking Therapeutics Inc.’s recent newsMarket Volume Report & Detailed Earnings Play Strategies - Newser
Is Viking Therapeutics Inc. exposed to political riskLayoff News & Fast Exit and Entry Trade Guides - خودرو بانک
Institutional scanner results for Viking Therapeutics Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Jim Cramer Expects Palantir To Reach New All-Time High - Benzinga
Forecasting Viking Therapeutics Inc. price range with options dataJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Exit strategy if you’re trapped in Viking Therapeutics Inc.Swing Trade & Community Trade Idea Sharing - Newser
Is Viking Therapeutics Inc. stock entering bullish territory2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Down 34%, Should You Buy the Dip on Viking Therapeutics? - AOL.com
How Viking and Axsome Stocks Could Double by 2030 - NAI500
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):